InsidersTradesSigma
Track the BIOSPECIFICS TECHNOLOGIES CORP share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 27 January 2016 (Levée d'options). Among the most active insiders: Schamroth Michael. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
BIOSPECIFICS TECHNOLOGIES CORP is a company focused on the development of biopharmaceutical products. It specializes in the research and commercialization of treatments based on biological specificity technologies.